Researchers compared intensive chemotherapy with single-agent clofarabine in fit older adults with newly diagnosed AML.
Early low-dose lenalidomide significantly reduces mutational burden without increasing AML risk in non-transfusion-dependent del(5q) MDS.
Recently updated change-of-control terms also fueled buyout chatter by outlining executive payouts and full equity ...
Endpoint Area listed Nov. 30 as the expected catalyst timing for Sellas’ Phase 3 GPS trial.
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an inflammatory ...